Pyridostigmine induced heart block requiring ICU admission

Myasthenia gravis is an autoimmune disorder that effects an estimated 20 people per 100,000 in the USA per year. Pyridostigmine is a common drug used in the symptomatic treatment of myasthenia gravis. While generally safe and effective, a rare set of patients treated with pyridostigmine encounter ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaucer, Benjamin, Whelan, Dustin, Lamichhane, Dronacharya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197028/
https://www.ncbi.nlm.nih.gov/pubmed/30357043
http://dx.doi.org/10.1080/20009666.2018.1527668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197028/
https://www.ncbi.nlm.nih.gov/pubmed/30357043
http://dx.doi.org/10.1080/20009666.2018.1527668

Ejemplares similares